harvardhealth_news_UNDEFINED
People who have gout, which results from excess uric acid in the body, are at increased risk for heart disease and stroke. A 2026 study found that maintaining uric acid levels below 6 mg/dL with medication reduced the risk for heart attack, stroke, and heart-related death.
Ankle osteoarthritis is often the consequence of old ankle injuries, such as sprains or fractures, that alter joint alignment. Treatment focuses on restoring mobility, strength, and proper alignment through targeted exercises, supportive footwear, orthotics, and braces.
Hand pain doesn’t have to mean giving up cooking. Simple strategies that focus on joint protection and ergonomics (use of tools that are comfortable and easy to operate) can help reduce strain. Many gadgets are available to help people perform basic kitchen tasks without pain.
Research suggests that people who stop taking GLP-1 weight-loss drugs typically regain all the weight they lost in under two years. To sustain their progress, these people should eat more protein, fiber, and healthy fats; eat on a consistent schedule; exercise; and prioritize sleep.
Osteoporosis, age-related disc degeneration, and poor posture can cause or worsen a curved upper spine (hyperkyphosis). Maintaining bone health and strengthening the muscles responsible for good posture can help to slow the development of a curved spine.
Chronic pain is linked to an increased risk of high blood pressure, which may be driven in part by depression, according to a 2026 study. Mind-body therapies and medications may help.
Bigeminy is a usually harmless heart rhythm problem caused by premature heartbeats that may cause palpitations. Possible triggers include caffeine, stress, and lack of sleep. People with additional symptoms may need further testing.
Wearing an Apple Watch capable of recording an electrocardiogram may increase the detection of atrial fibrillation in older adults at increased risk for stroke, according to a 2026 study.
Periodontal (gum) disease is linked to a higher risk of cardiovascular disease, possibly because gum disease can allow bacteria to enter the bloodstream, causing inflammation that damages blood vessels.
In late 2025, the FDA approved a nasal spray to treat a sporadic, rapid heart rhythm called paroxysmal supraventricular tachycardia (PSVT). The self-administered spray, called etripamil (Cardamyst), may help people avoid emergency room treatment for PSVT.